Obesity and impaired metabolic health are established risk factors for the non-
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …

SUMMARY majority of patients tend to have a mild illness, a minority of patients develop
severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly …

The description of a so-called cytokine storm in patients with COVID-19 has prompted
consideration of anti-cytokine therapies, particularly interleukin-6 antagonists. However …

Background The medium-term effects of Coronavirus disease (COVID-19) on organ health,
exercise capacity, cognition, quality of life and mental health are poorly understood …

As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there
have been increasing reports from Europe, North America, Asia, and Latin America …

Importance Coronavirus disease 2019 (COVID-19) continues to cause considerable
morbidity and mortality worldwide. Case reports of hospitalized patients suggest that COVID …

Abstract Coronavirus disease 2019 (COVID‐19), which began in Wuhan, China, in
December 2019, has caused a large global pandemic and poses a serious threat to public …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent pathogen
responsible for the coronavirus disease 2019 (COVID-19). Since its emergence, the novel …

Blood myeloid cells are known to be dysregulated in coronavirus disease 2019 (COVID-19),
caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with …

Background: The new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), has caused more than 210 000 deaths worldwide. However, little is known about …